Literature DB >> 3813704

Significance of metastatic disease in subaortic lymph nodes.

G A Patterson, D Piazza, F G Pearson, T R Todd, R J Ginsberg, M Goldberg, P Waters, D Jones, R Ilves, J D Cooper.   

Abstract

Thirty-five patients underwent resection of primary bronchogenic carcinoma of the left upper lobe or left main bronchus in the presence of metastatic disease in subaortic lymph nodes. No patient had metastatic disease in other mediastinal node stations. There was 1 postoperative death. Complete follow-up is available on 34 patients. Three-year and five-year actuarial survival for the entire group is 44% and 28%, respectively. For 23 patients undergoing complete resection, five-year actuarial survival is 42%. Resection of primary bronchogenic carcinoma in the presence of subaortic nodal metastases is associated with improved survival relative to reports of survival following resection of metastatic disease in other mediastinal node stations. Resection should be undertaken in these patients especially when it is judged that the resection is likely to be complete.

Entities:  

Mesh:

Year:  1987        PMID: 3813704     DOI: 10.1016/s0003-4975(10)60386-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

2.  Mediastinal lymphatic drainage from pulmonary lobe based on CT observations of histoplasmosis: implications for minimal N2 disease of non-small-cell lung cancer.

Authors:  Koji Takahashi; William Stanford; Edwin Van Beek; Brad Thompson; Brian Mullan; Yutaka Sato
Journal:  Radiat Med       Date:  2007-10-26

Review 3.  Invasive staging of the mediastinum.

Authors:  M R Johnston
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

4.  Anatomic basis of lymphatic spread from carcinoma of the lung to the mediastinum: surgical and prognostic implications.

Authors:  M Riquet
Journal:  Surg Radiol Anat       Date:  1993       Impact factor: 1.246

Review 5.  Mind-mapping for lung cancer: towards a personalized therapeutics approach.

Authors:  N Mollberg; M Surati; C Demchuk; R Fathi; A K Salama; A N Husain; T Hensing; R Salgia
Journal:  Adv Ther       Date:  2011-02-09       Impact factor: 3.845

Review 6.  Controversies regarding T status and N status for non-small cell lung cancer.

Authors:  Yanli Mo; Jiayin Peng; Wenmei Su; Xinggui Chen; Aibing Wu; Jinmei Li; Zhixiong Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 7.  Primary cancer of the lung in women.

Authors:  E B Smith
Journal:  J Natl Med Assoc       Date:  1989-09       Impact factor: 1.798

Review 8.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

9.  N2 disease in T1 non-small cell lung cancer.

Authors:  Sebastian A Defranchi; Stephen D Cassivi; Francis C Nichols; Mark S Allen; K Robert Shen; Claude Deschamps; Dennis A Wigle
Journal:  Ann Thorac Surg       Date:  2009-09       Impact factor: 4.330

Review 10.  Resection of stage III non-small cell lung cancer following induction therapy.

Authors:  V W Rusch
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.